Recommends 7.
That Member States should take note of the current autumn-winter risk period for FMD, given the high animal movements associated with the festival periods and the continued circulation in neighbourhood countries of diverse African and West Eurasian genotypes of four FMDV serotypes (O, A, Asia-1 and SAT2), and the risk situation for further movements of FMDV in the Mediterranean /north African area, and the circulation of type A viruses in East Asia and West Eurasia that threaten the Russian Federation and its European neighbours;
8.
That the WRL for FMD, taking guidance from the Standing Technical Committee, continues to produce a six-monthly update in the priorities for vaccine and antigen banks, but undertakes a thorough review of the system and classification of the priority levels and address the priorities according to the virus pools/regions;
9.
The funding of projects by the EuFMD-FAR following the review and findings of the STC, supporting their proposal for funding of one project as proposed, a further one subject to clarification, and of one component of another project (on wild boar surveillance);
10. That the STC, with the Special Committee for Research and Programme Development (SCRPD), consider if a targeted call to the EuFMD Fund for Research (“competition”) on model development is needed to ensure that the outcome is closer to the needs identified by the potential European users; 11. The SCRPD meeting establish if European focal points for contingency planning/modeling are needed, to better identify the European user needs and to ensure development in the field makes use of progress in other regions; 12. That a 2nd State of FMD Research report be commissioned, with a target date of April 2014; the STC to prepare the Terms of Reference for the authors, and the Secretariat identify the costs which should come within the identified budget ceiling for Component 1.5; 13. To prepare a paper on co-operation between vaccine bank managers in Europe – addressing issues relating to selection, coverage, replacement and supply to third party policies; 14. That the SCRPD meeting at Frascati in November consider how the members could contribute to the STC work on Horizon Scanning, with a view to a set of papers prepared in time for the 60th Anniversary in June 2014; 15. The Executive at the 87th Session consider the issue of improved co-operation between vaccine bank managers in Europe in relation to issues of selection, coverage, replacement and emergency arrangements including supply to third party policies.
th
86 Executive Committee meeting of the EuFMD, 17-18 October 2013, Lyons, France
4
